Benitec Biopharma
Benitec Biopharma is a biotechnology company specializing in the development of innovative genetic medicines using its proprietary DNA-directed RNA interference (ddRNAi) technology platform. Focused on addressing serious unmet medical needs, Benitec Biopharma advances therapeutic solutions for chronic and life-threatening diseases, including rare genetic disorders and infectious diseases. The company’s pipeline leverages RNA interference to silence disease-causing genes at the source, offering the potential for durable and transformative treatments. With a commitment to scientific excellence and patient-centric innovation, Benitec Biopharma collaborates with industry partners and research institutions to accelerate the development of next-generation gene therapies.
